Rolapitant Hydrochloride

CHEMBL3707330 Phase 4 अनुमोदित Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
555.0 g/mol
LogP
—
Phase
4

Rolapitant hydrochloride is the hydrochloride salt form of rolapitant, a neurokinin-1 (NK1) receptor antagonist used to prevent chemotherapy-induced nausea and vomiting. See rolapitant for complete pharmacological details.

आणविक भार

555.0000 g/mol

TPSA

51.40 Ų

चिकित्सीय क्षेत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl.O

InChI

InChI=1S/C25H26F6N2O2.ClH.H2O/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22;;/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34);1H;1H2/t16-,22-,23-;;/m1../s1

Molecular Formula

C25H29ClF6N2O3

HBD / HBA

4 / 10

घूर्णनीय बंधन

5

भारी परमाणु

37

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Rolapitant hydrochloride is the hydrochloride salt form of rolapitant, a neurokinin-1 (NK1) receptor antagonist used to prevent chemotherapy-induced nausea and vomiting. See rolapitant for complete pharmacological details.

Yes, Rolapitant Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3707330. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 16203739. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.